The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate...
The report includes the hopeful news that there were 42 new antibiotics in development as of June 2019.
WASHINGTON – Beta-lactams were noninferior to fluoroquinolones or trimethoprim-...
LJUBLJANA, SLOVENIA – Staphylococcus aureus resistance to vancomycin is not a one-way street ending in a cliff plunge.
Recarbrio is a three-drug combined injection of imipenem/cilastatin and relebactam.
Mortality rates topped 50% during a protracted outbreak at a Spanish hospital.
Can ASPs quantify their impact on antibiotic use without using an EMR or requiring IT support?
The EHR can be a tool to combat inappropriate antibiotic use – if it’s well designed.